WO2003033675A3 - Identification of binding partners for specific proteins - Google Patents

Identification of binding partners for specific proteins Download PDF

Info

Publication number
WO2003033675A3
WO2003033675A3 PCT/US2002/033511 US0233511W WO03033675A3 WO 2003033675 A3 WO2003033675 A3 WO 2003033675A3 US 0233511 W US0233511 W US 0233511W WO 03033675 A3 WO03033675 A3 WO 03033675A3
Authority
WO
WIPO (PCT)
Prior art keywords
dgi
relates
peptides
polypeptides
identification
Prior art date
Application number
PCT/US2002/033511
Other languages
French (fr)
Other versions
WO2003033675A2 (en
Inventor
Renuka Pillutla
Arthur J Blume
Neil I Goldstein
Original Assignee
Dgi Bio Technologies Inc
Renuka Pillutla
Arthur J Blume
Neil I Goldstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dgi Bio Technologies Inc, Renuka Pillutla, Arthur J Blume, Neil I Goldstein filed Critical Dgi Bio Technologies Inc
Priority to AU2002359281A priority Critical patent/AU2002359281A1/en
Publication of WO2003033675A2 publication Critical patent/WO2003033675A2/en
Publication of WO2003033675A3 publication Critical patent/WO2003033675A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

This invention relates to newly characterized protein DGI-3 and peptides ('DGI-3-binders') and polypeptides ('DGI-3-partners') that bind to this protein. Also related are polypeptide complexes comprising DGI-3 and DGI-3-binders or DGI-3 and DGI-3-partners, as well as antibodies that bind to these polypeptide complexes. Additionally, this invention relates to nucleic acids encoding the DGI-3, DGI-3-binder, or DGI-3-partner peptides or polypeptides. The invention also relates to diagnostics and therapeutics employing the disclosed DGI-3, DGI-3-binder, or DGI-3-partner polypeptides, peptides, or polynucletides. In particular, this invention relates to diagnostic and therapeutic applications directed to cancers and similar disorders.
PCT/US2002/033511 2001-10-19 2002-10-18 Identification of binding partners for specific proteins WO2003033675A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002359281A AU2002359281A1 (en) 2001-10-19 2002-10-18 Identification of binding partners for specific proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34289201P 2001-10-19 2001-10-19
US60/342,892 2001-10-19

Publications (2)

Publication Number Publication Date
WO2003033675A2 WO2003033675A2 (en) 2003-04-24
WO2003033675A3 true WO2003033675A3 (en) 2005-02-17

Family

ID=23343734

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/033511 WO2003033675A2 (en) 2001-10-19 2002-10-18 Identification of binding partners for specific proteins

Country Status (2)

Country Link
AU (1) AU2002359281A1 (en)
WO (1) WO2003033675A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2891663B8 (en) * 2012-08-31 2018-04-04 Vasculead Inc. Psf1-derived peptide
EP3077551B1 (en) * 2013-12-06 2020-04-01 President and Fellows of Harvard College Paper-based synthetic gene networks
WO2016116935A1 (en) * 2015-01-21 2016-07-28 Yeda Research And Development Co. Ltd. Use of rasa2 as a prognostic and therapeutic marker for melanoma
CA3078744A1 (en) * 2017-10-10 2019-04-18 Gritstone Oncology, Inc. Neoantigen identification using hotspots

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK 6 May 1998 (1998-05-06), KALINKE ET AL.: "In vitro afinity maturation of VSV-specific single-chain Fv antibody fragments" *

Also Published As

Publication number Publication date
AU2002359281A1 (en) 2003-04-28
WO2003033675A2 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
WO2002102993A3 (en) Human secreted proteins
WO2001055307A8 (en) Nucleic acids, proteins, and antibodies
WO2001054472A8 (en) Nucleic acids, proteins, and antibodies
WO2001055306A3 (en) Nucleic acids, proteins, and antibodies
WO2002077013A3 (en) Human secreted proteins
WO2003033675A3 (en) Identification of binding partners for specific proteins
WO2000059942A3 (en) Human obesity protein binding protrein-2 homolog and uses thereof
WO2003025147A3 (en) Novel polynucleotides and proteins encoded thereby
WO2000061754A3 (en) Human proteins and polynucleotides encoding them
WO2002059282A3 (en) Adipocyte complement related protein zacrp13
WO2001055168A8 (en) Nucleic acids, proteins and antibodies
WO2002072763A3 (en) Nucleic acids, proteins, and antibodies
WO2001027277A3 (en) Proteins and polynucleotides encoded thereby
WO2002077190A8 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002044373A3 (en) Adipocyte complement related protein zacrp12
WO2001055167A8 (en) Nucleic acids, proteins, and antibodies
WO2002070704A3 (en) Adipocyte complement related protein zacrp11
WO2001055162A8 (en) Nucleic acids, proteins, and antibodies
WO2003044160A3 (en) Novel molecules of the card related protein family and uses thereof
WO2001057087A3 (en) High affinity immunoglobulin epsilon receptor beta-subunit-like protein and nucleic acids encoding same
WO2001096399A3 (en) Novel interferon-induced tetraspan protein and nucleic acids encoding same
WO2001055305A8 (en) Nucleic acids, proteins, and antibodies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP